Back to Search Start Over

US FDA issues warning letters to two Chinese firms regarding data quality and integrity concerns, violative lab practices

Source :
PharmaBiz. September 13, 2024
Publication Year :
2024

Abstract

The US Food and Drug Administration (FDA) issued warning letters to two Chinese nonclinical testing laboratories, citing both for laboratory oversight failures and animal care violations that raise concerns about [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaBiz
Publication Type :
Periodical
Accession number :
edsgcl.808556708